Show simple item record

dc.contributor.authorAscierto, P
dc.contributor.authorGrimaldi, A
dc.contributor.authorCurti, B
dc.contributor.authorFaries, M
dc.contributor.authorFerrone, S
dc.contributor.authorFlaherty, K
dc.contributor.authorFox, B
dc.contributor.authorGajewski, T
dc.contributor.authorGershenwald, J
dc.contributor.authorGogas, H
dc.contributor.authorGrossmann, K
dc.contributor.authorHauschild, A
dc.contributor.authorHodi, F S
dc.contributor.authorKefford, R
dc.contributor.authorKirkwood, J
dc.contributor.authorLeachmann, S
dc.contributor.authorMaio, M
dc.contributor.authorMarais, Richard
dc.contributor.authorPalmieri, G
dc.contributor.authorMorton, D
dc.contributor.authorRibas, A
dc.contributor.authorStroncek, D
dc.contributor.authorStewart, R
dc.contributor.authorWang, E
dc.contributor.authorMozzillo, N
dc.contributor.authorMarincola, F
dc.date.accessioned2012-12-05T17:07:09Z
dc.date.available2012-12-05T17:07:09Z
dc.date.issued2012
dc.identifier.citationFuture perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". 2012, 10:83 J Transl Meden_GB
dc.identifier.issn1479-5876
dc.identifier.pmid22551296
dc.identifier.doi10.1186/1479-5876-10-83
dc.identifier.urihttp://hdl.handle.net/10541/254636
dc.description.abstractAfter more than 30 years, landmark progress has been made in the treatment of cancer, and melanoma in particular, with the success of new molecules such as ipilimumab, vemurafenib and active specific immunization.After the first congress in December 2010, the second edition of "Melanoma Research: a bridge from Naples to the World" meeting, organized by Paolo A. Ascierto (INT, Naples, Italy), Francesco M. Marincola (NIH, Bethesda, USA), and Nicola Mozzillo (INT, Naples, Italy) took place in Naples, on 5-6 December 2011. We have identified four new topics of discussion: Innovative Approaches in Prevention, Diagnosis and Surgical Treatment, New Pathways and Targets in Melanoma: An Update about Immunotherapy, and Combination Strategies. This international congress gathered more than 30 international faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive atmosphere which stimulated discussion of new approaches and strategies in the field of melanoma.
dc.language.isoenen
dc.rightsArchived with thanks to Journal of translational medicineen_GB
dc.subject.meshAnimals
dc.subject.meshAntineoplastic Agents
dc.subject.meshBiomedical Research
dc.subject.meshHumans
dc.subject.meshImmunotherapy
dc.subject.meshItaly
dc.subject.meshMelanoma
dc.subject.meshMice
dc.subject.meshRandomized Controlled Trials as Topic
dc.subject.meshSkin Neoplasms
dc.titleFuture perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".en
dc.typeArticleen
dc.contributor.departmentDepartment of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.en_GB
dc.identifier.journalJournal of Translational Medicineen_GB
html.description.abstractAfter more than 30 years, landmark progress has been made in the treatment of cancer, and melanoma in particular, with the success of new molecules such as ipilimumab, vemurafenib and active specific immunization.After the first congress in December 2010, the second edition of "Melanoma Research: a bridge from Naples to the World" meeting, organized by Paolo A. Ascierto (INT, Naples, Italy), Francesco M. Marincola (NIH, Bethesda, USA), and Nicola Mozzillo (INT, Naples, Italy) took place in Naples, on 5-6 December 2011. We have identified four new topics of discussion: Innovative Approaches in Prevention, Diagnosis and Surgical Treatment, New Pathways and Targets in Melanoma: An Update about Immunotherapy, and Combination Strategies. This international congress gathered more than 30 international faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive atmosphere which stimulated discussion of new approaches and strategies in the field of melanoma.


This item appears in the following Collection(s)

Show simple item record